Impaired monoamine and organic cation uptake in choroid plexus in mice with targeted disruption of the plasma membrane monoamine transporter (Slc29a4) gene

Journal of Biological Chemistry

Volumn 288, Issue 5, 2013, Pages 3535-3544

  Duan, Haichuan ^a   Wang, Joanne ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1-METHYL-4-PHENYLPYRIDINIUM; BIOACTIVE AMINES; BIOGENIC AMINES; CATIONIC DRUGS; EPITHELIAL CELLS; IMMUNOFLUORESCENCE STAINING; KNOCK OUTS; ORGANIC CATION TRANSPORTERS; ORGANIC CATIONS;

AMINES; CELL MEMBRANES; CEREBROSPINAL FLUID; GENES; MAMMALS; METABOLITES; TISSUE;

POSITIVE IONS;

1 METHYL 4 PHENYLPYRIDINIUM; CARRIER PROTEIN; MONOAMINE; PLASMA MEMBRANE MONOAMINE TRANSPORTER; UNCLASSIFIED DRUG;

AMINE TRANSPORT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATION TRANSPORT; CEREBROSPINAL FLUID; CHOROID PLEXUS; CONTROLLED STUDY; GENE DELETION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SLC29A4 GENE;

ANIMALS; BIOGENIC MONOAMINES; CATIONS; CELL MEMBRANE; CELL POLARITY; CHOROID PLEXUS; EPITHELIAL CELLS; EQUILIBRATIVE NUCLEOSIDE TRANSPORT PROTEINS; GENE DELETION; GENE EXPRESSION REGULATION; GENE TARGETING; HEK293 CELLS; HUMANS; INHIBITORY CONCENTRATION 50; MICE; MICE, INBRED C57BL; ORGANIC CATION TRANSPORT PROTEINS; PROTEIN TRANSPORT; RNA, MESSENGER; VESICULAR MONOAMINE TRANSPORT PROTEINS;

EID: 84873311854     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.436972     Document Type: Article

References (46)

1. Graff, C. L., and Pollack, G. M. (2004) Drug transport at the blood-brain barrier and the choroid plexus. Curr. Drug Metab. 5, 95-108
2. Kusuhara, H., and Sugiyama, Y. (2004) Efflux transport systems for organic anions and cations at the blood-CSF barrier. Adv. Drug Deliv. Rev. 56, 1741-1763
3. Redzic, Z. (2011) Molecular biology of the blood-brain and the bloodcerebrospinal fluid barriers. Similarities and differences. Fluids Barriers CNS 8, 3
4. Hu, Y., Shen, H., Keep, R. F., and Smith, D. E. (2007) Peptide transporter 2 (PEPT2) expression in brain protects against 5-aminolevulinic acid neurotoxicity. J. Neurochem. 103, 2058-2065
5. Leggas, M., Adachi, M., Scheffer, G. L., Sun, D., Wielinga, P., Du, G., Mercer, K. E., Zhuang, Y., Panetta, J. C., Johnston, B., Scheper, R. J., Stewart, C. F., and Schuetz, J. D. (2004) Mrp4 confers resistance to topotecan and protects the brain from chemotherapy. Mol. Cell. Biol. 24, 7612-7621
6. Sweet, D. H., Miller, D. S., Pritchard, J. B., Fujiwara, Y., Beier, D. R., and Nigam, S. K. (2002) Impaired organic anion transport in kidney and choroid plexus of organic anion transporter 3 (Oat3 (Slc22a8)) knockout mice. J. Biol. Chem. 277, 26934-26943
7. Sotiriou, S., Gispert, S., Cheng, J., Wang, Y., Chen, A., Hoogstraten-Miller, S., Miller, G. F., Kwon, O., Levine, M., Guttentag, S. H., and Nussbaum, R. L. (2002) Ascorbic-acid transporter Slc23a1 is essential for vitamin C transport into the brain and for perinatal survival. Nat. Med. 8, 514-517
8. Shu, C., Shen, H., Teuscher, N. S., Lorenzi, P. J., Keep, R. F., and Smith, D. E. (2002) Role of PEPT2 in peptide/mimetic trafficking at the bloodcerebrospinal fluid barrier. Studies in rat choroid plexus epithelial cells in primary culture. J. Pharmacol. Exp. Ther. 301, 820-829
9. Shen, H., Smith, D. E., Keep, R. F., Xiang, J., and Brosius, F. C., 3rd (2003) Targeted disruption of the PEPT2 gene markedly reduces dipeptide uptake in choroid plexus. J. Biol. Chem. 278, 4786-4791
10. Smith, D. E., Hu, Y., Shen, H., Nagaraja, T. N., Fenstermacher, J. D., and Keep, R. F. (2011) Distribution of glycylsarcosine and cefadroxil among cerebrospinal fluid, choroid plexus, and brain parenchyma after intracerebroventricular injection is markedly different between wild-type and Pept2 null mice. J. Cereb. Blood Flow Metab. 31, 250-261
11. Lindvall, M., Hardebo, J. E., and Owman, C. (1980) Barrier mechanisms for neutrotransmitter monoamines in the choroid plexus. Acta Physiol. Scand. 108, 215-221
12. Kaplan, G. P., Hartman, B. K., and Creveling, C. R. (1981) Localization of catechol-O-methyltransferase in the leptomeninges, choroid plexus and ciliary epithelium. Implications for the separation of central and peripheral catechols. Brain Res. 204, 353-360
13. Vitalis, T., Fouquet, C, Alvarez, C, Seif, I., Price, D., Gaspar, P., and Cases, O. (2002) Developmental expression of monoamine oxidases A and B in the central and peripheral nervous systems of the mouse. J. Comp. Neurol. 442, 331-347
14. Suzuki, H., Sawada, Y., Sugiyama, Y., Iga, T., and Hanano, M. (1986) Transport of cimetidine by the rat choroid plexus in vitro. J. Pharmacol. Exp. Ther. 239, 927-935
15. Miller, D. S., Villalobos, A. R., and Pritchard, J. B. (1999) Organic cation transport in rat choroid plexus cells studied by fluorescence microscopy. Am. J. Physiol. 276, C955-C968
16. Spector, R. (2010) Nature and consequences of mammalian brain and CSF efflux transporters. Four decades of progress. J. Neurochem. 112, 13-23
17. Pavone, L. M., Tafuri, S., Mastellone, V., Morte, R. D., Lombardi, P., Avallone, L., Maharajan, V., Staiano, N, and Scala, G. (2007) Expression of the serotonin transporter (SERT) in the choroid plexuses from buffalo brain. Anat. Rec. (Hoboken) 290, 1492-1499
18. Sweet, D. H., Miller, D. S., and Pritchard, J. B. (2001) Ventricular choline transport. A role for organic cation transporter 2 expressed in choroid plexus. J. Biol. Chem. 276, 41611-41619
19. Engel, K., Zhou, M., and Wang, J. (2004) Identification and characterization of a novel monoamine transporter in the human brain. J. Biol. Chem. 279, 50042-50049
20. Engel, K., and Wang, J. (2005) Interaction of organic cations with a newly identified plasma membrane monoamine transporter. Mol. Pharmacol. 68, 1397-1407
21. Zhou, M., Duan, H., Engel, K., Xia, L., and Wang, J. (2010) Adenosine transport by plasma membrane monoamine transporter. Reinvestigation and comparison with organic cations. Drug Metab. Dispos. 38, 1798-1805
22. Duan, H., and Wang, J. (2010) Selective transport of monoamine neurotransmitters by human plasma membrane monoamine transporter and organic cation transporter 3. J. Pharmacol. Exp. Ther. 335, 743-753
23. Vialou, V., Balasse, L., Dumas, S., Giros, B., and Gautron, S. (2007) Neurochemical characterization of pathways expressing plasma membrane monoamine transporter in the rat brain. Neuroscience 144, 616-622
24. Dahlin, A., Xia, L., Kong, W., Hevner, R., and Wang, J. (2007) Expression and immunolocalization of the plasma membrane monoamine transporter in the brain. Neuroscience 146, 1193-1211
25. Dahlin, A., Royall, J., Hohmann, J. G., and Wang, J. (2009) Expression profiling of the solute carrier gene family in the mouse brain. J. Pharmacol. Exp. Ther. 329, 558-570
26. Okura, T., Kato, S., Takano, Y., Sato, T., Yamashita, A., Morimoto, R., Ohtsuki, S., Terasaki, T., and Deguchi, Y. (2011) Functional characterization of rat plasma membrane monoamine transporter in the blood-brain and blood-cerebrospinal fluid barriers. J. Pharm. Sci. 100, 3924-3938
27. George, S. H., Gertsenstein, M., Vintersten, K., Korets-Smith, E., Murphy, J., Stevens, M. E., Haigh, J. J., and Nagy, A. (2007) Developmental and adult phenotyping directly from mutant embryonic stem cells. Proc. Natl. Acad. Sci. U. S. A. 104, 4455-4460
28. Teuscher, N S., Novotny, A., Keep, R. F., and Smith, D. E. (2000) Functional evidence for presence of PEPT2 in rat choroid plexus. Studies with glycylsarcosine. J. Pharmacol. Exp. Ther. 294, 494-499
29. Xia, L., Zhou, M., Kalhorn, T. F., Ho, H. T., and Wang, J. (2009) Podocytespecific expression of organic cation transporter PMAT. Implication in puromycin aminonucleoside nephrotoxicity. Am. J. Physiol. Renal. Physiol. 296, F1307-F1313
30. Praetorius, J., and Nielsen, S. (2006) Distribution of sodium transporters and aquaporin-1 in the human choroid plexus. Am. J. Physiol. Cell Physiol. 291, C59-C67
31. +-ATPase. Mol. Biol. Cell 18, 4508-4518
32. Koepsell, H., Lips, K., and Volk, C. (2007) Polyspecific organic cation transporters. Structure, function, physiological roles, and biopharmaceutical implications. Pharm. Res. 24, 1227-1251
33. Torres, G. E., Gainetdinov, R. R., and Caron, M. G. (2003) Plasma membrane monoamine transporters. Structure, regulation and function. Nat. Rev. Neurosci. 4, 13-25
34. Villalobos, A. R., Parmelee, J. T., and Pritchard, J. B. (1997) Functional characterization of choroid plexus epithelial cells in primary culture. J. Pharmacol. Exp. Ther. 282, 1109-1116
35. Choudhuri, S., Cherrington, N. J., Li, N., and Klaassen, C. D. (2003) Constitutive expression of various xenobiotic and endobiotic transporter mRNAs in the choroid plexus of rats. Drug Metab. Dispos. 31, 1337-1345
36. Xia, L., Engel, K., Zhou, M., and Wang, J. (2007) Membrane localization and pH-dependent transport of a newly cloned organic cation transporter (PMAT) in kidney cells. Am. J. Physiol. Renal. Physiol. 292, F682-F690
37. Itagaki, S., Ganapathy, V., Ho, H. T., Zhou, M., Babu, E., and Wang, J. (2012) Electrophysiological characterization of the polyspecific organic cation transporter plasma membrane monoamine transporter. Drug Metab. Dispos. 40, 1138-1143
38. Smith, D. E., Johanson, C. E., and Keep, R. F. (2004) Peptide and peptide analog transport systems at the blood-CSF barrier. Adv. Drug Deliv. Rev. 56, 1765-1791
39. Ho, H. T., Dahlin, A., and Wang, J. (2012) Expression profiling of solute carrier gene families at the blood-CSF barrier. Front. Pharmacol. 3, 154
40. Otsuka, M., Matsumoto, T., Morimoto, R., Arioka, S., Omote, H., and Moriyama, Y. (2005) A human transporter protein that mediates the final excretion step for toxic organic cations. Proc. Natl. Acad. Sci. U. S. A. 102, 17923-17928
41. Pasqualetti, M., Ori, M., Castagna, M., Marazziti, D., Cassano, G. B., and Nardi, I. (1999) Distribution and cellular localization of the serotonin type 2C receptor messenger RNA in human brain. Neuroscience 92, 601-611
42. 125I]SB-258585. Brain Res. 934, 49-57
43. Mignini, F., Bronzetti, E., Felici, L., Ricci, A., Sabbatini, M., Tayebati, S. K., and Amenta, F. (2000) Dopamine receptor immunohistochemistry in the rat choroid plexus. J. Auton. Pharmacol. 20, 325-332
44. Ho, H. T., Pan, Y., Cui, Z., Duan, H., Swaan, P. W., and Wang, J. (2011) Molecular analysis and structure-activity relationship modeling of the substrate/inhibitor interaction site of plasma membrane monoamine transporter. J. Pharmacol. Exp. Ther. 339, 376-385
45. + as environmental neurotoxins, in Neurotoxic Factors in Parkinson's Disease and Related Disorders (Storch, A., and Collins, M. A., eds) pp. 115-130, Kluwer Academic Publishing/Plenum, New York
46. Nagatsu, T. (1997) Isoquinoline neurotoxins in the brain and Parkinson's disease. Neurosci. Res. 29, 99-111